BridgeBio Pharma to Participate in the J.P. Morgan Healthcare Conference

BridgeBio PharmaJan 8 00:00 ET

BofA Securities Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $45

Moomoo NewsJan 6 06:31 ET · Ratings

S&P 500 Futures Drop In Premarket Trading; Sportradar Group, Cytokinetics Lead

Dow JonesDec 27, 2024 07:30 ET

BridgeBio Pharma Is Maintained at Outperform by Evercore ISI Group

Dow JonesDec 23, 2024 13:05 ET · Ratings

Evercore Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Raises Target Price to $50

Moomoo NewsDec 23, 2024 09:32 ET · Ratings

Piper Sandler Maintains BridgeBio Pharma(BBIO.US) With Buy Rating, Maintains Target Price $46

Moomoo NewsDec 18, 2024 18:32 ET · Ratings